| HIV Infection |
1 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.99 |
| Atherosclerosis |
0 |
0.88 |
| Coronary Heart Disease Risk Factors |
0 |
0.88 |
| Lipids Management |
0 |
0.88 |
| Cardiovascular Risk Management |
0 |
0.73 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.65 |
| Artery |
0 |
0.65 |
| Cardiometabolic Risk Factors |
0 |
0.48 |
| Heart Failure (HF) |
0 |
0.16 |
| Cardiovascular Imaging |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Hypertension |
0 |
0.14 |
| Hospital |
0 |
0.09 |
| Stress |
0 |
0.09 |
| Viral Load |
0 |
0.09 |
| Protease Inhibitor |
0 |
0.08 |
| AIDS |
0 |
0.05 |
| Angiography |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| CT Scan |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Exercise |
0 |
0.05 |
| Generics |
0 |
0.05 |
| Massachusetts |
0 |
0.05 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.05 |
| Proteases |
0 |
0.05 |
| Spain |
0 |
0.05 |
| Statins |
0 |
0.05 |
| Obesity |
0 |
0.04 |